FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells

Oncogene

Volumn 24, Issue 8, 2005, Pages 1434-1444

  Belguise, Karine ^a   Kersual, Nathalie ^a   Galtier, Florence ^a   Chalbos, Dany ^a  

^a INSERM   (France)

Author keywords

Breast cancer cells; Cell proliferation; FRA 1; Gene expression; In vitro invasion

Indexed keywords

BETA1 INTEGRIN; ESTROGEN RECEPTOR; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIGEL; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; FIBROBLAST; GENE ACTIVATION; GENE INACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANTIGENS, CD29; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; DOXYCYCLINE; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTOR AP-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 14844290887     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208312     Document Type: Article

References (59)

1. Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M, Berezin V, Bock E, Lukanidin E and Tulchinsky E. (2002). Oncogene, 21, 4843-4848.
2. Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P. (1987). Mol. Cell. Biol., 7, 2256-2266.
3. Bakiri L, Matsuo K, Wisniewska M, Wagner EF and Yaniv M. (2002). Mol. Cell. Biol., 22, 4952-4964.
4. Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G. (1993). Genes Dev., 7, 812-821.
5. Bamberger AM, Methner C, Lisboa BW, Stadtler C, Schulte HM, Loning T and Milde-Langosch K. (1999). Int. J. Cancer, 84, 533-538.
6. Bamberger AM, Milde-Langosch K, Schulte HM and Loning T. (2000). Horm. Res., 54, 32-37.
7. Benbrook DM and Jones NC. (1990). Oncogene, 5, 295-302.
8. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D. (2000). Nat. Cell Biol., 2, 737-744.
9. Bergers G, Graninger P, Braselmann S, Wrighton C and Busslinger M. (1995). Mol. Cell. Biol., 15, 3748-3758.
10. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA. (1993). Crit. Rev. Oral Biol. Med., 4, 197-250.
11. Brinckerhoff CE, Rutter JL and Benbow U. (2000). Clin. Cancer Res., 6, 4823-4830.
12. Brown PH, Kim SH, Wise SC, Sabichi AL and Birrer MJ. (1996). Cell Growth Differ., 8, 1013-1021.
13. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A. (1996). Nature, 380, 435-439.
14. Chalbos D, Vignon F, Keydar I and Rochefort H. (1982). J. Clin. Endocrinol. Metab., 55, 276-283.
15. Chinenov Y and Kerppola TK. (2001). Oncogene, 20, 2438-2452.
16. Clark GM, Osborne CK and McGuire WL. (1984). J. Clin. Oncol., 2, 1102-1109.
17. Cook SJ, Aziz N and McMahon M. (1999). Mol. Cell. Biol., 19, 330-341.
18. Coussens LM, Tinkle CL, Hanahan D and Werb Z. (2000). Cell, 103, 481-490.
19. Egeblad M and Werb Z. (2002). Nat. Rev. Cancer, 2, 161-174.
20. Fidler IJ and Ellis LM. (1994). Cell, 79, 185-188.
21. Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight III WA, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE and Ford HC. (1981). Breast Cancer Res. Treat., 1, 37-41.
22. Gasparini G. (2000). Oncologist, 5 (Suppl 1), 37-44.
23. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
24. Gruda MC, Kovary K, Metz R and Bravo R. (1994). Oncogene, 9, 2537-2547.
25. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K. (1992). FEBS Lett., 298, 29-32.
26. Hua J and Muschel RJ. (1996). Cancer Res., 56, 5279-5284.
27. Kurd TW, Culbert AA, Webster KJ and Tavare JM. (2002). Biochem. J., 368, 573-580.
28. Krueger JS, Keshamouni VG, Atanaskova N and Reddy KB. (2001). Oncogene, 20, 4209-4218.
29. Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E and Tulchinsky E. (1998). Mol. Cell. Biol., 18, 7095-7105.
30. Li G, Fridman R and Kim HR. (1999). Cancer Res., 59, 6267-6275.
31. Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld RA and Xiang R. (2003). Proc. Natl. Acad. Sci. USA, 100, 8850-8855.
32. Matsui M, Tokuhara M, Konuma Y, Nomura N and Ishizaki R. (1990). Oncogene, 5, 249-255.
33. McGuire WL. (1975). Annu. Rev. Med., 26, 353-363.
34. Mechta F, Lallemand D, Pfarr CM and Yaniv M. (1997). Oncogene, 14, 837-847.
35. Ozanne BW, McGarry L, Spence HJ, Johnston I, Winnie J, Meagher L and Stapleton G. (2000). Eur. J. Cancer, 36, 1640-1648.
36. Philips A, Chalbos D and Rochefort H. (1993). J. Biol. Chem., 268, 14103-14108.
37. Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H and Chalbos D. (1998). Mol. Endocrinol., 12, 973-985.
38. Price DJ, Miralem T, Jiang S, Steinberg R and Avraham H. (2001). Cell. Growth Differ., 12, 129-135.
39. Ramos-Nino ME, Timblin CR and Mossman BT. (2002). Cancer Res., 62, 6065-6069.
40. Schreiber M, Wang ZQ, Jochum W, Fetka I, Elliott C and Wagner EF. (2000). Development, 127, 4937-4948.
41. Shan B and Lee WH. (1994). Mol. Cell. Biol., 14, 8166-8173.
42. Shaulian E and Karin M. (2002). Nat. Cell Biol., 4, E131-E136.
43. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ. (1999). Oncogene, 18, 6063-6070.
44. Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP. (1994). Breast Cancer Res. Treat., 31, 325-335.
45. Stein B, Rahmsdorf HJ, Steffen A, Litfin M and Herrlich P. (1989). Mol. Cell. Biol., 9, 5169-5181.
46. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H and Iba H. (1991). Nucleic Acids Res., 19, 5537-5542.
47. Tang DG, Tarrien M, Dobrzynski P and Honn KV. (1995). J. Cell. Physiol., 165, 291-306.
48. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S and Lippman ME. (1992). J. Cell. Physiol., 150, 534-544.
49. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A and Verde P. (1997). EMBO J., 16, 5310-5321.
50. Vial E, Sahai E and Marshall CJ. (2003). Cancer Cell, 4, 67-79.
51. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. (1994). Nature, 369, 669-671.
52. Wisdom R and Verma IM. (1993). Mol. Cell. Biol., 13, 7429-7438.
53. Yoshiji H, Gomez DE, Shibuya M and Thorgeirsson UP. (1996a). Cancer Res., 56, 2013-2016.
54. Yoshiji H, Gomez DE and Thorgeirsson UP. (1996b). Int. J. Cancer, 69, 131-134.
55. Yoshiji H, Harris SR, Raso E, Gomez DE, Lindsay CK, Shibuya M, Sinha CC and Thorgeirsson UP. (1998). Int. J. Cancer, 75, 81-87.
56. Yoshioka K, Deng T, Cavigelli M and Karin M. (1995). Proc. Natl. Acad. Sci. USA, 92, 4972-4976.
57. Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C, Hsu TC and Colburn NH. (2002). Mol. Cell. Biol., 22, 587-598.
58. Yu JY, DeRuiter SL and Turner DL. (2002). Proc. Natl. Acad. Sci. USA, 99, 6047-6052.
59. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP and Johnson PH. (2001). Cancer Res., 61, 5168-5178.